Skip to main content
SpringerLink
Log in

Fewer bone histomorphometric abnormalities with intermittent than with continuous slow-release sodium fluoride therapy

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

To help resolve the uncertainty whether sodium fluoride (NaF) therapy should be given intermittently or continuously, we examined iliac crest bone biopsies (before and after treatment) and fragility fracture rates in 35 intermittently treated (group I) and 69 continuously treated (group C) patients; all received calcium. The following statistically significant results were obtained. Reduction in vertebral fracture rate was similar in the two groups. Trabecular thickness and the structurally more important mineralized thickness increased only in group I. Group I also accumulated less excess osteoid (surface, volume). Mean osteoid thickness did not change in either group because of a bimodal distribution of wide seams with osteoblasts and double tetracycline labels, and thin seams without osteoblasts or labels. Osteoid was lamellar. Osteoid in abnormal sites (within bone marrow or bone, or around osteocytes) was found less frequently in group I. Adjusted apposition rate declined and mineralization lag time increased in both groups because of extended unlabelled osteoid seams. Erosion surface increased only in group C. Hook and/or tunnel erosion was seen less frequently in group I; it was closely associated with osteoid in abnormal sites and correlated with osteoid surface. Extended osteoid surface may have forced osteoclasts to hollow out trabeculae, leaving the empty osteoid shell in marrow. Excess osteoid volume and eroded surface and osteoid and erosion in abnormal sites correlated with bone fragility in group C. We conclude that intermittent therapy is to be preferred because it (1) increased mineralized trabecular thickness, (2) did not cause excessive osteoid accumulation and erosion, (3) showed less osteoid and erosion in abnormal sites and (4) led to a similar reduction in the vertebral fracture rate as did continuous treatment. The question of whether intermittency of therapy has some other effect independent of the cumulative dose of fluoride administered cannot be answered by this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Meunier PJ, Boivin G. Fluoride salts for vertebral osteoporosis: the benefit-to-risk ratio depends on the cumulative dose reaching bone. Osteoporos Int 1993; 3(Suppl 1):S211–4.

    Google Scholar 

  2. Kleerekoper M. Mendlovic B. Sodium fluoride therapy of postmenopausal osteoporosis. Endocr Rev 1993; 14:312–23.

    Google Scholar 

  3. Mamelle N, Meunier PJ, Dusan R, Gillaume M, Martin JL, Gaucher A, et al. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet 1988;2:361–5.

    Google Scholar 

  4. Pak CYC, Sakhaee K, Piziak V, Petersen RD, Breslau NA, Boyd P, et al. Slow-release sodium fluoride in the management of postmenopausal osteoporosis. Ann Intern Med 1994; 120:625–32.

    Google Scholar 

  5. Nagant de Deuxchaisnes C, de Vogelaer JP, Depresseux G, Malghem J, Maldague B. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements. J Bone Miner Res 1990;5(Suppl 1):S5–26.

    Google Scholar 

  6. Riggs BL, Hodgson SF. O'Fallon WM, Chao EYS, Wahner HW, Muhs JM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322:802–9.

    Google Scholar 

  7. Riggs BL, O'Fallon WM, Lane A, Hodgson SF. Wahner HW, Muhs J, et al. Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis. J Bone Miner Res 1994;9:265–75.

    Google Scholar 

  8. Lundy MW, Stauffer M, Werdedal JE, Baylink DJ, Featherstone JDB, Hodgson SF, Riggs BL. Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos Int 1995;5:115–29.

    Google Scholar 

  9. Zerwekh JE, Antich PP, Sakhaee K, Prior J, Gonzales J, Gottschalk F, Pak CYC. Lack of deleterious effect of slow-release sodium fluoride treatment on cortical bone histology and quality in osteoporotic patients. Bone Miner 1992;18:65–76.

    Google Scholar 

  10. Schnitzler CM, Pitchford DGK, Willis EM, Gear KA. Comparison of the radiographic vertebral trabecular pattern with the vertebral fracture prevalence and spinal bone density. Osteoporos Int 1993;3:293–9.

    Google Scholar 

  11. Melsen F, Mosekilde L. The role of bone biopsy in the diagnosis of metabolic bone disease. Orothop Clin North Am 1988;12:571–602.

    Google Scholar 

  12. Malluche HH, Meyer W, Sherman D, Massry SG. Quantitative bone histology in 84 normal American subjects: morphometric analysis and evaluation of variance in iliac bone. Calcif Tissue Int 1982;34:449–55.

    Google Scholar 

  13. Schnitzler CM, Mesquita JM, Gear KA, Robson HJ, Moodley GP, Smyth AE. Iliac bone biopsies at the time of periarticular stress fractures during fluoride therapy: comparison with pretreatment biopsies. J Bone Miner Res 1990;5:141–52.

    Google Scholar 

  14. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche HH, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols and units. J Bone Miner Res 1987;2:595–610.

    Google Scholar 

  15. Boivin G, Chapuy MC, Baud CA, Meunier PJ. Fluoride content in human iliac bone: results in controls, patients with fluorosis, and osteoporotic patients treated with fluoride. J Bone Miner Res 1988;3:497–502.

    Google Scholar 

  16. Eastell R, Cedel SL, Wahner HW, Riggs BL, Melton LJ III. Classification of vertebral fractures. J Bone Miner Res 1991;6:207–15.

    Google Scholar 

  17. Smith-Bindman R, Cummings SR, Steiger P, Genant HK. A comparison of morphometric definitions of vertebral fracture. J Bone Miner Res 1991;6:25–34.

    Google Scholar 

  18. Gallagher JC, Hedlund LR, Stoner S, Meeger C. Vertebral morphometry: normative data. Bone Miner 1988;4:189–96.

    Google Scholar 

  19. Malluche HH, Faugere MC. Evaluation of mineralized bone histology. In: Malluche HH, Faugere MC. Atlas of mineralized bone histology. Basel: Karger, 1986:37–48.

    Google Scholar 

  20. Bell GH, Dunbar O, Beck JS, Gibb A. Variations in strength of vertebrae with age and their relation to osteoporosis. Calcif Tissue Res 1967;1:75–86.

    Google Scholar 

  21. Kleerekoper M, Balena R, Foldes J, Shih MS, Rao D. Histomorphometric changes in iliac bone induced by sodium fluoride therapy depend on cumulative dose (abstract). J Bone Miner Res 1990;5(Suppl 2):S140.

    Google Scholar 

  22. Eriksen EF, Mosekilde L, Melsen F. Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics. Bone 1985;6:381–9.

    Google Scholar 

  23. Boivin G. Morphometric analysis of fluorotic bone tissue. In: Courvoisier B, Donath A, Baud CA, editors. Fluoride and bone. Bern: Hans Huber, 1978:42–6.

    Google Scholar 

  24. Olah AJ, Reutter FW, Dambacher MA. Effects of combined therapy with sodium fluoride and high doses of vitamin D in osteoporosis: a histomorphometric study in the iliac crest. In: Courvoisier B, Donath A, Baud CA, editors. Fluoride and bone. Bern: Hans Huber, 1978:242–4.

    Google Scholar 

  25. Franke J. Our experience in the treatment of osteoporosis with relatively low sodium fluoride doses. In: Courvoisier B, Donath A, Baud CA, editors. Fluoride and bone. Bern: Hans Huber, 1978:256–62.

    Google Scholar 

  26. Briancon D, Meunier PJ. Treatment of osteoporosis with fluoride, calcium and vitamin D. Orthop Clin North Am 1981;12:629–48.

    Google Scholar 

  27. Aaron JE, de Vernejoul M-C, Kanis JA. The effect of sodium fluoride on trabecular architecture. Bone 1991;12:307–10.

    Google Scholar 

  28. Zerwekh JE, Hagler HK, Sakhaee K, Gottschalk F, Petersen RD, Pak CYC. Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis. Bone 1994;15:691–9.

    Google Scholar 

  29. Schenk RK, Merz WA, Reutter FW. Fluoride in osteoporosis. In: Vischer TL, editor. Fluoride in medicine. Bern: Hans Huber, 1970:153–68

    Google Scholar 

  30. Ringe JD, Krase HP, Kuhlencordt F. Treatment of primary osteoporosis by sodium fluoride. In: Courvoisier B, Donath A, Baud CA, editors. Fluoride and bone. Bern: Hans Huber, 1978:228–32.

    Google Scholar 

  31. Reutter FW, Olah AJ. Bone biopsy findings and clinical observations in longterm treatment of osteoporosis with sodium fluoride and vitamin D3. In: Courvoisier B, Donath A, Baud CA, editors. Fluoride and bone. Bern: Hans Huber, 1978:249–55.

    Google Scholar 

  32. Boivin G, Duriez J, Chapuy MC, Flautre B, Hardouin P, Meunier PJ. Relationship between bone fluoride content and histological evidence of calcification defects in osteoporotic women treated long term with sodium fluoride. Osteoporos Int 1993;3:204–8.

    Google Scholar 

  33. Kuhlencordt F, Kruse HP, Eckermeier L, Luzano-Tonkin C. The histological evaluation of bone in fluoride treated osteoporosis. In: Vischer TL, editor. Fluoride in medicine. Bern: Hans Huber, 1970:169–74.

    Google Scholar 

  34. Jensen KS, Mosekilde Lis, Mosekilde Leif. A model of vertebral trabecular bone architecture and its mechanical properties. Bone 1990;11:417–23.

    Google Scholar 

  35. Reutter FW, Siebenmann R, Pajarola M. Fluoride in osteoporosis. In: Vischer TL, editor. Fluoride in medicine. Bern: Hans Huber, 1970:143–52.

    Google Scholar 

  36. Kruse HP, Kuhlencordt F, Ringe JD. Ergebnisse einer Langzeitherapie der primären Osteoporose mit Natrium-fluorid. Dtsch Med Wochenschr 1978;103:248–52.

    Google Scholar 

  37. Boivin G, Chavassieux P, Chapuy MC, Baud CA, Meunier PJ. Skeletal fluorosis: histomorphometric findings. J Bone Miner Res 1990; 5(Suppl 1):S185–9.

    Google Scholar 

  38. Bang S, Baud CA. Topographical distribution of fluoride in iliac bone of a fluoride-treated osteoporotic patient. J Bone Miner Res 1990;5(Suppl 1):S87–9.

    Google Scholar 

  39. Pak CYC, Sakhaee K, Bell NH, Licata A, Johnston C, Rubin B, et al. Comparison of non-randomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis. J Bone Miner Res 1996; 11:160–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Baragwanath Hospital, University of the Witwatersrand, Johannesburg

    C. M. Schnitzler & J. M. Mesquita

  2. Department of Medicine, Johannesburg Hospital, and University of the Witwatersrand, Johannesburg

    J. R. Wing, F. J. Raal & M. T. van der Merwe

  3. Metabolic Bone Disease Clinic, Johannesburg Hospital, and University of the Witwatersrand, Johannesburg

    K. A. Gear & H. J. Robson

  4. Department of Medicine, Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa

    R. Shires

Authors
  1. C. M. Schnitzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. R. Wing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. J. Raal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. T. van der Merwe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. M. Mesquita
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. A. Gear
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. J. Robson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Shires
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schnitzler, C.M., Wing, J.R., Raal, F.J. et al. Fewer bone histomorphometric abnormalities with intermittent than with continuous slow-release sodium fluoride therapy. Osteoporosis Int 7, 376–389 (1997). https://doi.org/10.1007/BF01623781

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01623781

Keywords

Search

Navigation